NCT00400530View on ClinicalTrials.gov

Upper GI Handling of Branded vs. Generic Alendronate

PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2005

Conditions
Osteoporosis
Interventions
DRUG

MK0217, alendronate sodium / Duration of Treatment: 1 Month

DRUG

Comparator: Alendronate-Teva / Duration of Treatment: 1 Month

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00400530 - Upper GI Handling of Branded vs. Generic Alendronate | Biotech Hunter | Biotech Hunter